The Cell–Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression

Cited by (104)

Items 101–104 of 104

1. Helping the released guardian: Drug combinations for supporting the anticancer activity of HDM2 (MDM2) antagonists
   Kocik, Justyna, Machula, Monika, Wisniewska, Aneta, Surmiak, Ewa, Holak, Tad A., Skalniak, Lukasz · 2019 · Cancers
2. Differential Induction of Reactive Oxygen Species and Expression of Antioxidant Enzymes in Human Melanocytes Correlate with Melanin Content: Implications on the Response to Solar UV and Melanoma Susceptibility
   Upadhyay, Parth R., Starner, Renny J., Swope, Viki B., Wakamatsu, Kazumasa, Ito, Shosuke, Abdel-Malek, Zalfa A. · 2022 · Antioxidants
3. MDM2 inhibition in the treatment of glioblastoma: From concept to clinical investigation
   Pellot Ortiz, Karolina I., Rechberger, Julian S., Nonnenbroich, Leo F., Daniels, David J., Sarkaria, Jann N. · 2023 · Biomedicines
4. Disordered regions mediate the interaction of p53 and MRE11
   Usluer, Sinem, Galhuber, Markus, Khanna, Yukti, Bourgeois, Benjamin, Spreitzer, Emil, Michenthaler, Helene, Prokesch, Andreas, Madl, Tobias · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research